17.61

7.37% -1.3875

Stevanato Group Spa (STVN)

Overview News Price History Option Chain Why STVN Down? Discussions Forecast Dividend History

Stevanato Group Spa stock is traded at $17.61, with a volume of 574.94K. It is down -7.37% in the last 24 hours and down -3.93% over the past month. Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Previous Close:

$19.00

Open:

$19

24h Volume:

574.94K

Relative Volume:

1.09

Market Cap:

$5.00B

Revenue:

$1.18B

Net Income/Loss:

$132.61M

P/E Ratio:

29.53

EPS:

0.5964

Net Cash Flow:

$-276.17M

1W Performance:

-17.33%

1M Performance:

-3.93%

6M Performance:

-15.02%

1Y Performance:

-35.27%

1-Day Range:

$17.49

$19.38

1-Week Range:

$17.49

$22.07

52-Week Range:

$16.56

$34.73

Stevanato Group Spa Stock (STVN) Company Profile

Name

Stevanato Group Spa

Sector

Healthcare (1200)

Industry

Medical Instruments & Supplies (58)

Phone

Address

Employee

5,635

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

STVN's Discussions on Twitter

Compare STVN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STVN	17.62	5.00B	1.18B	132.61M	-276.17M	0.5964
ISRG	531.92	190.83B	7.87B	2.24B	586.00M	4.25
BDX	224.06	65.14B	20.18B	1.73B	3.07B	5.51
ALC	85.87	42.50B	9.76B	1.16B	665.00M	0.72
RMD	238.96	35.17B	4.81B	1.11B	1.35B	6.16
WST	306.69	22.30B	2.88B	499.60M	321.60M	7.41

Stevanato Group Spa Stock (STVN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-22-24	Initiated	Exane BNP Paribas	Outperform
Nov-01-23	Downgrade	Jefferies	Buy → Hold
Sep-26-23	Initiated	Stephens	Overweight
Sep-19-23	Initiated	CJS Securities	Market Outperform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-10-21	Initiated	BofA Securities	Buy
Aug-10-21	Initiated	Citigroup	Buy
Aug-10-21	Initiated	Jefferies	Buy
Aug-10-21	Initiated	KeyBanc Capital Markets	Overweight
Aug-10-21	Initiated	Morgan Stanley	Overweight
Aug-10-21	Initiated	Wells Fargo	Overweight

View All

Stevanato Group Spa Stock (STVN) Latest News

Nov 15, 2024

Objective long/short (STVN) Report - Stock Traders Daily

Nov 15, 2024

Frank Sands Reduces Stake in Stevanato Group SpA - GuruFocus.com

Nov 15, 2024

Stevanato S p A : 2R Vials and Deep Cold StorageDetermining Mechanical & CCI performances - Marketscreener.com

Nov 15, 2024

Nov 14, 2024

Significant Acquisition by T. Rowe Price Investment Management i - GuruFocus.com

Nov 14, 2024

Pharmaceutical Visual Inspection Systems Market Report: - openPR

Nov 14, 2024

Nov 13, 2024

Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement - Seeking Alpha

Nov 13, 2024

Nov 12, 2024

Stevanato Group's (NYSE:STVN) Anemic Earnings Might Be Worse Than You Think - Simply Wall St

Nov 12, 2024

Earnings Troubles May Signal Larger Issues for Stevanato Group (NYSE:STVN) Shareholders - Yahoo Finance

Nov 12, 2024

Nov 11, 2024

Stevanato Group to Present at Upcoming Investor Conferences - The Bakersfield Californian

Nov 11, 2024

Stevanato Group to Present at Three Major Healthcare Investor Conferences in Q4 | STVN Stock News - StockTitan

Nov 11, 2024

Nov 08, 2024

Auto-injectors: syringe-based and cartridge-based autoinjectors - Stevanato Group

Nov 08, 2024

Wellington Management Group LLP Bolsters Position in Stevanato G - GuruFocus.com

Nov 08, 2024

Stevanato Group S.p.A. Just Missed EarningsBut Analysts Have Updated Their Models - Simply Wall St

Nov 08, 2024

Medical devices assembly lines - Stevanato Group

Nov 08, 2024

Nov 07, 2024

Stevanato Group S.p.A. (NYSE:STVN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024

Nov 06, 2024

Citi maintains buy on Stevanato Group with $28 target - Investing.com India

Nov 06, 2024

Earnings call: Stevanato Group reports modest growth, eyes future recovery - Investing.com

Nov 06, 2024

Stevanato Group Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 06, 2024

Citi maintains buy on Stevanato Group with $28 target By Investing.com - Investing.com UK

Nov 05, 2024

Stevanato Group SpA earnings missed by €0.02, revenue topped estimates - Investing.com

Nov 05, 2024

Stevanato Group (STVN) Q3 Earnings Match Estimates - Yahoo Canada Finance

Nov 05, 2024

Stevanato: Q3 Earnings Snapshot - San Antonio Express-News

Nov 05, 2024

Stevanato Group Reports Financial Results for the Third Quarter of 2024 - The Bakersfield Californian

Nov 05, 2024

Stevanato Group S.P.A. Provides Earnings Guidance for the Full Year 2024 - Marketscreener.com

Nov 05, 2024

Nov 04, 2024

(STVN) Trading Signals - Stock Traders Daily

Nov 04, 2024

What's Next: Stevanato Gr's Earnings Preview - Benzinga

Nov 04, 2024